Ultima actualizare: august 17, 2026
Stem Cells Treatment for multiple sclerosis (MS).
Interim results from an international trial of a stem cell transplant treatment showed a much higher success rate than the control group, which received a drug treatment. MS is a disease that affects the brain, măduva spinării, and immune system, leading to a number of disabilities. The stem cell treatment uses chemotherapy to wipe out a patient’s immune system and then “re-boots” it using stem cells from the patient’s blood and bone marrow that are unaffected by the disease.
Just over 100 people participated in the study in four cities: in Chicago, Sao Paolo, Sheffield (U.K.), and Uppsala in Sweden. They all had relapsing remitting MS, where periods of symptomatic “relapses” alternate with periods of remission. A year after the treatment, only one patient who received the stem cell treatment had relapsed, compared to 39 people in the control group.
In a follow-up an average of three years after treatment, cel celule stem had failed in 6% (3 of 52) of recipients while the drug treatment had failed in 60% (30 of 50). The results were released at the annual meeting of the European Society for Bone and Marrow Transplantation in Lisbon.
A neurologist at Royal Hallamshire Hospital in the U.K. told the BBC this was the best result he had seen “in any trial for multiple sclerosis,” though he included the caveat that the results were only preliminary.
This study is the largest of its kind, and it bolsters results from smaller trials that have also showed stem cell transplant to be effective.
Solicitare de informații prin WhatsApp :
)
)
)e-mail: [email protected]
Analiza științifică a cazului
Doriți să înțelegeți dacă programele clinice actuale, evoluții recente ale cercetării, sau abordări emergente pot fi relevante pentru situația dumneavoastră individuală?
Distribuiți întrebarea dvs. echipei noastre de cercetare științifică și primiți informaţii concentrate pe domeniile de cercetare curentă care pot fi relevante pentru cazul dvs.
- Revizuirea informațiilor pe care le furnizați
- Informații relevante de cercetare și program clinic
- Un răspuns clar concentrat pe situația dvs
Fără obligație. Întrebarea dvs. va fi examinată în mod confidențial.
Doar informații educaționale și de cercetare. Acest serviciu nu constituie un sfat medical, diagnostic, prescripție medicală, sau personalizat recomandare de tratament.
